Oppenheimer & Co. Inc. Sells 90,494 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Oppenheimer & Co. Inc. lowered its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 44.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 113,860 shares of the company’s stock after selling 90,494 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $1,640,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Brown Brothers Harriman & Co. purchased a new position in shares of BlackRock Health Sciences Term Trust during the third quarter valued at about $32,000. Brown Lisle Cummings Inc. grew its holdings in BlackRock Health Sciences Term Trust by 17.0% in the fourth quarter. Brown Lisle Cummings Inc. now owns 42,711 shares of the company’s stock worth $615,000 after purchasing an additional 6,198 shares during the period. Stifel Financial Corp grew its holdings in shares of BlackRock Health Sciences Term Trust by 2.2% during the third quarter. Stifel Financial Corp now owns 414,346 shares of the company’s stock valued at $6,563,000 after buying an additional 8,843 shares during the last quarter. K2 Principal Fund L.P. purchased a new stake in shares of BlackRock Health Sciences Term Trust during the third quarter valued at approximately $158,000. Finally, Jane Street Group LLC bought a new position in BlackRock Health Sciences Term Trust during the third quarter valued at approximately $357,000.

BlackRock Health Sciences Term Trust Stock Performance

Shares of BlackRock Health Sciences Term Trust stock opened at $15.53 on Tuesday. The company’s 50 day moving average is $15.68 and its 200 day moving average is $15.67. BlackRock Health Sciences Term Trust has a twelve month low of $14.27 and a twelve month high of $16.75.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently disclosed a monthly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were given a dividend of $0.1773 per share. The ex-dividend date was Friday, February 14th. This represents a $2.13 dividend on an annualized basis and a yield of 13.70%.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.